AACR to Host Seventh Annual International Conference on Frontiers in Cancer Prevention Research
November 12, 2008
WASHINGTON, D.C. - The American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research will focus on the latest biological, medical and social research behind cancer prevention. The conference will be held November 16 - 19, 2008, at the Gaylord National Convention Center in Washington, D.C., and more than 1,000 scientists and other professionals are expected to attend.
"This meeting has become a major venue for presenting cutting-edge research in basic, clinical, epidemiologic and behavioral science," said meeting chair Steven M. Dubinett, M.D., director of the Lung Cancer Research Program at the UCLA Jonsson Comprehensive Cancer Center. "As the only comprehensive conference on cancer prevention in the world, it continues to foster important transdisciplinary interactions that are vital to making critical discoveries."
The 2008 program will cover a wide variety of cancer prevention topics and will specifically highlight some of the latest developments in the tumor microenvironment, international prevention mechanisms, integrative prevention and targeted prevention and treatment.
This international conference will bring together scientists and other professionals, working in a variety of disciplines, to discuss the latest findings in the field and to stimulate the development of new research in cancer prevention.
The AACR will host six press briefings for reporters during the conference that will include breaking news:
A groundbreaking scientific partnership with the Avon/Love Army of Women that will recruit one million healthy women for clinical trials.
- How DNA methylation may explain why some smokers get lung cancer while others do not.
- Why family history may affect the risk of breast cancer associated with BRCA1/BRCA2 genetic mutations.
- How canola oil affects a person's risk for cancer.
- New data on alcohol and its effect on esophageal cancer.
This popular Frontiers in Cancer Prevention Research conference promotes public, academic, government and industry awareness of the vital importance of cancer prevention science in reducing cancer incidence and mortality. It catalyzes coordinated, focused research that promises to accelerate cancer prevention. The exciting ideas presented at this conference will benefit the work of investigators in every prevention subspecialty and at every level of career development.
# # #
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes more than 28,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and 80 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes five major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention. The AACR's most recent publication and its sixth major journal, Cancer Prevention Research, is dedicated exclusively to cancer prevention, from preclinical research to clinical trials. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.
In Washington, D.C., Nov. 16-18: 301-965-5422